Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Drug-drug interactions: antiretroviral drugs and recreational drugs.
Staltari O, Leporini C, Caroleo B, Russo E, Siniscalchi A, De Sarro G, Gallelli L. Staltari O, et al. Among authors: leporini c. Recent Pat CNS Drug Discov. 2014;9(3):153-63. doi: 10.2174/1574889809666141127101623. Recent Pat CNS Drug Discov. 2014. PMID: 25429704 Review.
Pharmacovigilance and drug safety in Calabria (Italy): 2012 adverse events analysis.
Giofrè C, Scicchitano F, Palleria C, Mazzitello C, Ciriaco M, Gallelli L, Paletta L, Marrazzo G, Leporini C, Ventrice P, Carbone C, Saullo F, Rende P, Menniti M, Mumoli L, Chimirri S, Patanè M, Esposito S, Cilurzo F, Staltari O, Russo E, De Sarro G; UNIVIGIL CZ Group. Giofrè C, et al. Among authors: leporini c. J Pharmacol Pharmacother. 2013 Dec;4(Suppl 1):S55-60. doi: 10.4103/0976-500X.120963. J Pharmacol Pharmacother. 2013. PMID: 24347984 Free PMC article.
Adverse drug reactions reporting in Calabria (Southern Italy) in the four-year period 2011-2014: impact of a regional pharmacovigilance project in light of the new European Legislation.
Leporini C, Marrazzo G, Mumoli L, Esposito S, Gallelli L, Mangano G, Brancati G, De Francesco EA, Russo E, De Sarro G; UNIVIGIL CZ Research Group. Leporini C, et al. Expert Opin Drug Saf. 2017 May;16(5):515-522. doi: 10.1080/14740338.2017.1316486. Epub 2017 Apr 19. Expert Opin Drug Saf. 2017. PMID: 28395523
Implementing a simple pharmacovigilance program to improve reporting of adverse events associated with biologic therapy in rheumatology: Preliminary results from the Calabria Biologics Pharmacovigilance Program (CBPP).
Palleria C, Iannone L, Leporini C, Citraro R, Manti A, Caminiti M, Gigliotti P, Grembiale RD, L'Andolina M, Muccari G, Naturale MD, Olivo D, Pagano Mariano G, Pellegrini R, Varcasia G, Abdalla K, Russo E, Ursini F, De Sarro G. Palleria C, et al. Among authors: leporini c. PLoS One. 2018 Oct 24;13(10):e0205134. doi: 10.1371/journal.pone.0205134. eCollection 2018. PLoS One. 2018. PMID: 30356301 Free PMC article.
42 results